EDITORIAL
How good is the evidence for ambulatory oxygen in chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder characterized by small and large airway dysfunction and destruction of the lung parenchyma and vasculature in highly variable combinations.' Breathlessness and exercise intolerance are the most common symptoms in COPD and both progress relentlessly through the natural history ofdisease and may be accompanied by the development of chronic hypoxaemia. Long term oxygen therapy (LTOT) in resting hypoxaemic COPD patients has physiological benefits (for example, reversal of polycythemia, improved exercise performance, improved neurological status, reduced pulmonary hypertension) and together with pulmonary rehabilitation may improve health related quality of life (HRQL).2-8 Furthermore only LTOT and smoking cessation have been shown to improve survival in patients with COPD.2'3 In a survey of patients with severe COPD treated with LTOT, 50% did not leave the house (MRC dyspnoea grade 5) and 78% were breathless while walking around at home and perforning activities of daily living (ADL).9 In advanced COPD, hypoxaemia usually worsens during exercise and induces a transient but marked elevation of pulmonary artery pressure (PAP). This can be as high as 20-30 mmlHg during a steady state (40 watt) exercise task. Breathing oxygen during exercise produces a small but significant fall of PAP and pulmonary vascular resistance. 0 Accordingly it is logical that oxygen should be prescribed during exercise to patients prescribed LTOT.4 The prescription of ambulatory oxygen therapy to patients with significant hypoxaemia only during exertion is still under discussion. Ambulatory oxygen is defined as oxygen delivered by equipment that can be carried by most patients.'1 In the UK this is provided with small oxygen cylinders lasting one to three hours at a 2 L/min-1 flow. Other countries, such as the USA and Italy, provide liquid oxygen in portable strollers that allow for longer periods of autonomy (up to 10 hours at 2 L min i). Both these systems are used without sufficient supporting evidence."1 Nevertheless ambulatory oxygen therapy has widely been shown to increase exercise performance and to relieve exercise dyspnoea in patients with COPD.12-16 The main mechanism for the effect of oxygen on exercise tolerance has recently been clarified. 17 Recent studies indicate that reduction in hyperinflation plays an important role in the oxygen related relief of dyspnoea.12,16 Interestingly, supplemental oxygen generally increases exercise tolerance in patients with only mild to moderate hypoxaemia that is not severe enough to meet guidelines for LTOT.12"18"19 However, little is known about the effectiveness of ambulatory oxygen therapy when used for longer periods in addition to stationary oxygen delivery. An attempt to evaluate the efficacy of long term ambulatory oxygen therapy in patients with chronic lung disease on exercise capacity, symptom perception and other relevant measurements of improvement was recently made by a systematic review.11 In this review, 90 abstracts and 17 full text papers were examined but only two trials20'21 investigating the effects of ambulatory oxygen therapy in COPD met the inclusion criteria"1 and indicated that the treatment of COPD patients with ambulatory domiciliary oxygen therapy failed to show any consistent benefit. There was no clear effect of oxygen therapy on exercise capacity, dyspnoea, HRQL or lung function. One study20 reported significant improvements in minute ventilation and PaO2 that was not reported by the other.2' McDonald et al. 21 concluded that although oxygen supplementation induced some acute increments in exercise performance, such improvements had little impact on patients' ADL. However their patients did not suffer from severe hypoxaemia and would not have met the criteria for LTOT, unlike the patients of Lilker et al. 20 who concluded that ambulatory oxygen therapy was of more value than placebo in a selected group of COPD patients with cor pulmonale and resting hypoxaemia.
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program. Exercise was on cycle ergometers for 45 min, three times a week; as the program proceeded the work rate was progressively increased. During exercise they received either oxygen (3 L min-1) or compressed air (3 L min-) by nasal cannulae. Both groups had higher exercise tolerance while breathing air after training. However, the oxygen trained group increased training intensity more rapidly over the seven weeks than the control group. After training, exercise endurance increased significantly more in the oxygen trained group (213%) than in controls (170%). In contrast to those on LTOT the available evidence to date does not allow any firm conclusion concerning the routine use of ambulatory oxygen therapy in patients with COPD without resting hypoxaemia.
